H35.073
Retinal telangiectasis, bilateral
Clinical Classification Guidelines
Medical Intelligence & Overview
Bilateral retinal telangiectasis is a condition characterized by abnormal dilation of the small blood vessels (capillaries) in both retinas. This condition affects the eye's retina, which is crucial for vision as it captures light and sends visual signals to the brain. When these blood vessels become dilated or malformed, it can lead to visual disturbances and, if left untreated, may cause more serious eye problems. Recognizing this condition early is important for managing potential complications and preserving vision.
Causes & Symptoms
Clinical Causes: Genetic factors that affect blood vessel development Age-related changes in blood vessels Underlying systemic conditions such as hypertension or diabetes Vascular inflammation or other eye diseases Unknown, sometimes idiopathic in nature
Key Symptoms: Mild visual disturbances such as blurred vision Seeing floaters or spots in the vision Altered color perception Difficulty with low-light vision In advanced cases, there may be visual field defects
Diagnostic & Treatment
Diagnosis Path: Diagnosis is typically made through a comprehensive eye examination, which includes the use of ophthalmoscopy to visually assess the retina. Additional diagnostic tests may include fluorescein angiography, where a special dye is injected to highlight the blood vessels in the retina, and optical coherence tomography (OCT), which provides detailed cross-sectional images of retinal tissue. These procedures help in identifying abnormal blood vessels and assessing the extent of retinal changes.
Treatment Protocols: Management of bilateral retinal telangiectasis depends on the severity and progression of the condition. Common treatment options include:
Clinical Advice & FAQs
Billing Guidance
Is H35.073 a billable ICD-10 code?
Yes, H35.073 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.073?
Clinical documentation must specify the nature of Retinal telangiectasis, bilateral and any associated comorbidities for accurate reporting.
Cite this Clinical Reference